{"result": "(\"entity\"<|>HCU GEL<|>ORGANIZATION<|>HCU Gel is a nutritional supplement used to manage metabolic disorders related to amino acids, particularly in patients with urea cycle disorders.)\n##\n(\"entity\"<|>HCU EXPRESS<|>ORGANIZATION<|>HCU Express is a nutritional supplement designed to support metabolic control in individuals with amino acid metabolism issues.)\n##\n(\"entity\"<|>HCU COOLER 15<|>ORGANIZATION<|>HCU Cooler 15 is a specialized nutritional product aimed at providing essential amino acids for metabolic support.)\n##\n(\"entity\"<|>XMET<|>ORGANIZATION<|>XMET is a brand of nutritional supplements that includes various formulations to aid in amino acid metabolism and support metabolic health.)\n##\n(\"entity\"<|>HOM 1<|>ORGANIZATION<|>HOM 1 is a nutritional supplement that provides essential nutrients for individuals with metabolic disorders.)\n##\n(\"entity\"<|>HOM 2<|>ORGANIZATION<|>HOM 2 is a dietary supplement aimed at addressing deficiencies in amino acid metabolism.)\n##\n(\"entity\"<|>UREA CYCLE DISORDERS<|>EVENT<|>Urea cycle disorders are genetic conditions that result in a deficiency of one of the enzymes in the urea cycle, leading to the accumulation of ammonia in the body.)\n##\n(\"entity\"<|>PIRIDOXINA<|>ORGANIZATION<|>Pyridoxine (Vitamin B6) is a cofactor used in the treatment of metabolic disorders to help maintain amino acid levels.)\n##\n(\"entity\"<|>CISTATIONINA<|>ORGANIZATION<|>Cystathionine is an amino acid that plays a role in the metabolism of homocysteine and is important for brain metabolism.)\n##\n(\"entity\"<|>TAURINA<|>ORGANIZATION<|>Taurine is an amino acid that is necessary for various metabolic processes, including brain function.)\n##\n(\"entity\"<|>AMONIO<|>ORGANIZATION<|>Ammonia is a toxic byproduct of protein metabolism that can accumulate in the body due to urea cycle disorders.)\n##\n(\"entity\"<|>GLUTAMINA<|>ORGANIZATION<|>Glutamine is an amino acid that can accumulate in the body and is involved in various metabolic processes.)\n##\n(\"entity\"<|>ALANINA<|>ORGANIZATION<|>Alanine is an amino acid that can be affected in metabolic disorders and is involved in energy metabolism.)\n##\n(\"entity\"<|>GLICINA<|>ORGANIZATION<|>Glycine is an amino acid that plays a role in various metabolic pathways and can accumulate in certain conditions.)\n##\n(\"relationship\"<|>HCU GEL<|>UREA CYCLE DISORDERS<|>HCU Gel is used as a treatment for individuals suffering from urea cycle disorders to manage their metabolic needs.<|>8)\n##\n(\"relationship\"<|>HCU EXPRESS<|>UREA CYCLE DISORDERS<|>HCU Express is utilized in the management of urea cycle disorders to provide essential nutrients.<|>8)\n##\n(\"relationship\"<|>HCU COOLER 15<|>UREA CYCLE DISORDERS<|>HCU Cooler 15 is designed to support individuals with urea cycle disorders by supplying necessary amino acids.<|>8)\n##\n(\"relationship\"<|>XMET<|>UREA CYCLE DISORDERS<|>XMET products are formulated to assist in the management of urea cycle disorders through nutritional support.<|>8)\n##\n(\"relationship\"<|>HOM 1<|>UREA CYCLE DISORDERS<|>HOM 1 is a supplement that addresses nutritional deficiencies in patients with urea cycle disorders.<|>8)\n##\n(\"relationship\"<|>HOM 2<|>UREA CYCLE DISORDERS<|>HOM 2 is aimed at providing essential nutrients for individuals affected by urea cycle disorders.<|>8)\n##\n(\"relationship\"<|>PIRIDOXINA<|>UREA CYCLE DISORDERS<|>Pyridoxine is administered to help manage symptoms and maintain amino acid levels in urea cycle disorders.<|>7)\n##\n(\"relationship\"<|>CISTATIONINA<|>UREA CYCLE DISORDERS<|>Cystathionine is crucial for the metabolism of homocysteine, which is relevant in urea cycle disorders.<|>6)\n##\n(\"relationship\"<|>TAURINA<|>UREA CYCLE DISORDERS<|>Taurine is necessary for brain metabolism and is important in the context of urea cycle disorders.<|>6)\n##\n(\"relationship\"<|>AMONIO<|>UREA CYCLE DISORDERS<|>Ammonia accumulation is a key issue in urea cycle disorders, leading to toxicity.<|>9)\n##\n(\"relationship\"<|>GLUTAMINA<|>UREA CYCLE DISORDERS<|>Glutamine can accumulate in urea cycle disorders, contributing to metabolic imbalances.<|>7)\n##\n(\"relationship\"<|>ALANINA<|>UREA CYCLE DISORDERS<|>Alanine levels can be affected in individuals with urea cycle disorders, impacting their metabolism.<|>6)\n##\n(\"relationship\"<|>GLICINA<|>UREA CYCLE DISORDERS<|>Glycine can accumulate in urea cycle disorders, affecting metabolic processes.<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: gún respuesta, para mejorar el control metabólico.\nde ser necesario emplear suplementos con aa esenciales,\nenriquecido en cisteína (Cys) y micronutrientes y sin Met,          5.   Errores innatos del ciclo de la urea\nrepartido entre las comidas. Con este fin se emplean:\nHCU gel®, HCU express®, HCU cooler 15®, XMET Ana-                   5.1.   Consideraciones generales\nlog®, XMET Maxamaid®, XMET Maxamum®, XMET Ho-                         Estos errores innatos del metabolismo se diagnosti-\nmidon® (95% aa sin Met), HOM 1® y HOM 2®.                           can en uno de cada 20000-30000 nacidos vivos (se\n    Es imprescindible aportar la energía suficiente para            cree que afectan a 1/8500) y están causados por la\nevitar el catabolismo proteico y conseguir el adecuado              deficiencia de actividad de cualquiera de las seis enzi-\ncrecimiento y desarrollo, para lo que se emplean suple-             mas implicadas (figura 4, tabla 7) en la conversión de\nmentos bajos en proteínas junto con los alimentos.                  amonio en urea (dos amonios por cada urea), que se\n                                                                    produce en diversos órganos, pero de forma completa\n4.5. Otros tratamientos22, 23                                       únicamente en el hígado. La herencia es autosómica\n    a. Aporte de los productos deficitarios de la reac-             recesiva en todos los casos, salvo la deficiencia de orni-\n                                                                    tín-transcarbamilasa (OTC, el más frecuente), que es\n       ción afectada. Es preciso incrementar Cys, que se            dominante ligada al X, por lo que se afectan todos los\n       ha convertido en esencial, y para ello se aportan            varones pero las mujeres heterocigotas en grado varia-\n       100 mg/kg/día de L-cistina, que logra mantener la            ble según la afectación hepática25-27.\n       síntesis de cistationina y taurina, que son necesa-\n       rias para el metabolismo cerebral.                           5.2.   Manifestaciones clínicas\n    b. Estimulación de la actividad enzimática. Se admi-\n       nistra piridoxina (B6), que es cofactor de la cista-           Los síntomas se producen por acumulación de amo-\n       tionina β sintetasa, a las dosis justas para mante-          nio, tóxico para el cerebro, y glutamina (Gln), alanina y\n       ner los niveles plasmáticos de homocisteína y Met            glicina (Gly) que pueden producir edema cerebral. La\n       más bajos; las dosis suelen ser de 150 mg/día en             forma clásica de presentación neonatal da lugar a un\n---\n                                                   Tema 18.      Soporte nutricional en metabolopatías de los aminoácidos…                        315\n\n\n\n                                              OAA                         α-KG\n                                        Glu       Asp aminotransferasa              Asp\n                                                                    Citrulina              ASS              Argsucc\n\n\n\n                                        Glu                                                           ASL\n                                             NAGS                   Citrulina                                         Fumarato\n                                                                                                            Arg\n                       HCO–        N-AcetilGlu                    OTC\n                            3            +\n                                        CPS             CarbamilP                                     ASA\n                     NH+4                                                                                              UREA\n                                                                     Ornitina                            Ornitina\n                      aa\n                                        Mitocondria                                                    Citoplasma\n\n\n\n                                                        CarbamilP                                   Orotato\n                  Figura 4.     Ciclo de la urea. aa: aminoácidos; Arg: arginina; Argsucc: argininosuccinato;\n                  Asp: aspartato; a-KG: a-cetoglutarato; carbamilP: carbamilfosfato; Glu: glutamato;\n                  OAA: oxalacetato. En azul, enzimas; ASA: arginasa; ASL: arginosuccínico liasa;\n                  ASS: arginosuccínico sintetasa; CPS: carbamilfosfato sintetasa; NAGS:\n                  N-acetilglutamato sintetasa; OTS: ornitín transcarbamilasa.\n\n\n\n                  Tabla 7.    Aspectos diferenciales entre las distintas deficiencias causantes del errores\n                  innatos del ciclo de la urea.\n\n\n\n                       Deficiencia               Sangre                 Orina                         Tratamiento\n                    NAGS                    ↑ Gly                                       Dar N-carbamilglutamato\n                    CPS                     ↑ Gly                                       Dar citrulina\n                    OTS                     ↑ Gly                  ↑↑ Orótico           Dar citrulina\n                    ASS                     ↑↑ Citrulina           ↑ Orótico            ↑↑ aporte de Arg\n                    ASL                     ↑ Citrulina,           ↑ Orótico,           ↑↑ aporte de Arg\n                                            ↑ Argsucc              ↑↑ Argsucc\n                    ASA                     ↑↑ Arg,                ↑ Arg                Restricción y no aporte de Arg\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}